Biotechnology
Biden administration to provide free Covid vaccines to uninsured Americans this fall through end of 2024
A healthcare worker prepares a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, on Wednesday, Jan. 26, 2022. Vanessa Leroy | Bloomberg | Getty Images The Biden administration on Thursday announced a program to provide free Covid vaccines to uninsured Americans through December 2024 after […]
Read More
Biden administration asks Pfizer, Moderna and Novavax for ‘reasonable’ prices on updated Covid vaccines
A nurse prepares doses of the Pfizer vaccine on Dec. 30, 2021, during a COVID-19 vaccination event at Josephine’s Southern Cooking in Chatham, Illinois. Brian Cassella | Tribune News Service | Getty Images The Biden administration on Thursday urged Pfizer, Moderna and Novavax to price their updated Covid vaccines at a “reasonable” rate when they […]
Read More
FDA approves first over-the-counter birth control pill
HRA Pharma expects a final decision by the FDA this summer on its application for nonprescription sales of Opill, which is generically called norgestrel. Source: Perrigo The Food and Drug Administration on Thursday approved the first over-the-counter birth control pill, a landmark decision that will allow more women and girls in the U.S. to prevent […]
Read More
Chamber of Commerce asks judge to block Medicare drug price negotiations before October 1
The U.S. Chamber of Commerce seal is displayed during restoration at the headquarters in Washington, D.C. Andrew Harrer | Bloomberg | Getty Images The U.S. Chamber of Commerce on Wednesday asked a federal judge in Ohio to block Medicare’s new powers to negotiate drug prices before October 1. The motion for a preliminary injunction is […]
Read More
Nvidia invests $50 million in biotech company Recursion for AI drug discovery
A man wearing a mask walks past a Nvidia logo in Taipei, Taiwan. Sopa Images | Lightrocket | Getty Images Chipmaker Nvidia will invest $50 million in Recursion Pharmaceuticals to speed up the development of the biotech firm’s artificial intelligence models for drug discovery, the companies said Wednesday. Recursion’s stock soared 80% following the announcement. […]
Read More
Illumina hit with record $476 million fine for closing Grail deal without EU approval
Rafael Henrique | Lightrocket | Getty Images European Union regulators on Wednesday fined Illumina a record 432 million euros ($476 million) for closing its acquisition of cancer test developer Grail without first securing regulatory approval. The European Commission’s fine amounts to 10% of San Diego-based Illumina’s turnover, the maximum allowed under E.U. merger rules. The […]
Read More
EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs
In this photo illustration, boxes of the diabetes drug Ozempic rest on a pharmacy counter on April 17, 2023 in Los Angeles, California. Mario Tama | Getty Images The European Union’s drug regulator on Tuesday said it has broadened an investigation into the risk of suicidal thoughts and self-injury among patients taking Novo Nordisk‘s Ozempic, […]
Read More
Few patients continue weight loss drugs like Wegovy after a year — but health costs soar for all
A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, March 31, 2023. Jim Vondruska | Reuters Only around one-third of patients prescribed weight loss drugs such as Novo Nordisk‘s blockbuster injection Wegovy continued to take it a year later — but total health-care costs […]
Read More
White House unveils plan to eliminate threat of fentanyl laced with xylazine
Bags of heroin, some laced with fentanyl, are displayed before a press conference at the office of the New York Attorney General regarding a major drug bust, Sept. 23, 2016. Drew Angerer | Getty Images The Biden administration unveiled a plan Tuesday to eliminate the growing threat of fentanyl laced with xylazine, an illegal street […]
Read More
Novavax stock spikes 20% after company snags $350 million from Canada for unused Covid shots
Nikos Pekiaridis | Nurphoto | Getty Images Stock Chart IconStock chart icon Novavax shares jump on news of a settlement payment from the Canadian government. It’s unclear how many doses of Novavax’s jab – its only commercially available product after 35 years – went unused. Under the amended agreement, Novavax will also provide Canada with […]
Read More